SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-18-019058
Filing Date
2018-10-30
Accepted
2018-10-30 16:07:14
Documents
10
Period of Report
2018-10-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20181030_8k.htm 8-K 31539
2 EXHIBIT 99.1 ex_126995.htm EX-99.1 4901
3 slide08.jpg GRAPHIC 54460
4 slide07.jpg GRAPHIC 129423
5 slide06.jpg GRAPHIC 192669
6 slide05.jpg GRAPHIC 165746
7 slide04.jpg GRAPHIC 187999
8 slide03.jpg GRAPHIC 60724
9 slide02.jpg GRAPHIC 272286
10 slide01.jpg GRAPHIC 54460
  Complete submission text file 0001437749-18-019058.txt   1578075
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 181147026
SIC: 2834 Pharmaceutical Preparations